510(k) · Cleared
ClearedChampion Iontophoretic Drug Delivery Device
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Iomed, Inc. · EGJ Device, Iontophoresis, Other Uses
Cleared on Feb 28, 2007 as substantially equivalent to K974855 (Iomed, Inc., 1998) and 3 other predicates after a 104-day review. Its family tree reaches back 5 generations to 1991. 1 later device descends from it.
- Decided
- Feb 28, 2007
- Review
- 104 days
- Class
- Class II
- Product code
- EGJ
- Recalls
- None
- Predicates
- 4
Its longest line of descent runs back 5 generations to K912015 (1991). 12 ancestors in all. 1 later device descends from it, 1 citing it directly.
- Root · 5 generations backK912015 TBD, Empi Buffered Iontophoresis Electroded MDL. 3Empi · 1991
- 4 generations backK970491 Dupel II Buffered Iontophoresis ElectrodesEmpi · 1997
- 3 generations backK983484 Dupel B.L.U.E. Small Iontophoresis ElectrodeEmpi · 1998
- 2 generations backK031115 RH-900Iomed, Inc. · 2003
- 1 generation backK033192 RH-950Iomed, Inc. · 2003
- This deviceK063465 Champion Iontophoretic Drug Delivery DeviceIomed, Inc. · 2007
- Descendant · cites it directly · 0 of its ownK072946 Hybresis Iontophoresis Drug Delivery SystemEmpi · 2007
Most influential descendants
Showing 1 of 1 · See all- K072946Hybresis Iontophoresis Drug Delivery SystemEmpi · 2007 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −5 | K912015 | TBD, Empi Buffered Iontophoresis Electroded MDL. 3 | Empi | 1991 | — |
| −4 | K970491 | Dupel II Buffered Iontophoresis Electrodes | Empi | 1997 | — |
| −3 | K983484 | Dupel B.L.U.E. Small Iontophoresis Electrode | Empi | 1998 | — |
| −2 | K031115 | RH-900 | Iomed, Inc. | 2003 | — |
| −1 | K033192 | RH-950 | Iomed, Inc. | 2003 | — |
| 0 (this device) | K063465 | Champion Iontophoretic Drug Delivery Device | Iomed, Inc. | 2007 | — |
| +1 | K072946 | Hybresis Iontophoresis Drug Delivery System | Empi | 2007 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1991 | 1 | 0 |
| 1994 | 4 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2007 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in EGJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new EGJ device
- #1 K242041 STOPWET iontophoresis apparatus (SW01)score 9.7 · 3 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (4)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K974855 | Phoresor II, Model PM900Summary page 1…hampion lontophoretic Drug Delivery System Common Name: lontophoresis Drug Delivery Device B. Name of Predicate Device(s) ! Jontophoresis Device: K974855 and K982668 lontophoresis Drug Delivery Device JOMED, Inc. Phoresor® II PM900 * lontophoresis Device: K932621… | 1998 |
| * | K982668 | Phoresor II,Model PM900Summary page 1…ophoretic Drug Delivery System Common Name: lontophoresis Drug Delivery Device B. Name of Predicate Device(s) ! Jontophoresis Device: K974855 and K982668 lontophoresis Drug Delivery Device JOMED, Inc. Phoresor® II PM900 * lontophoresis Device: K932621 Jonto… | 1999 |
| * | K932621 | RH-801/GS Model Transq (R)1Summary page 1…Device(s) ! Jontophoresis Device: K974855 and K982668 lontophoresis Drug Delivery Device JOMED, Inc. Phoresor® II PM900 * lontophoresis Device: K932621 Jontophoresis Drug Delivery Device IOMED, Inc. TQ1 RH-801/GS * lontophoresis Device: K033192 lontophore… | 1994 |
| * | K033192 | RH-950Summary page 1…MED, Inc. Phoresor® II PM900 * lontophoresis Device: K932621 Jontophoresis Drug Delivery Device IOMED, Inc. TQ1 RH-801/GS * lontophoresis Device: K033192 lontophoresis Drug Delivery Electrode IOMED, Inc. RH1-950 C. Device Description An iontophoresis device is a de… | 2003 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K072946 | Hybresis Iontophoresis Drug Delivery System | 2007 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All EGJ devicesEGJ Device, Iontophoresis, Other Uses: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.
FDA decisions per year · EGJ
1in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · EGJ
104in 2007
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · EGJ
1in 2021
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · EGJ
3in 2025
MAUDE reports naming product code EGJ, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 5 | 104 | 0 | 1 |
| 2008 | 2 | — | 0 | 6 |
| 2009 | 2 | — | 0 | 10 |
| 2010 | 0 | — | 0 | 21 |
| 2011 | 1 | — | 0 | 9 |
| 2012 | 0 | — | 0 | 8 |
| 2013 | 0 | — | 0 | 1 |
| 2014 | 1 | — | 0 | 1 |
| 2015 | 2 | — | 0 | 2 |
| 2016 | 0 | — | 0 | 3 |
| 2017 | 1 | — | 0 | 3 |
| 2018 | 1 | — | 0 | 8 |
| 2019 | 1 | — | 0 | 2 |
| 2020 | 1 | — | 0 | 2 |
| 2021 | 0 | — | 1 | 0 |
| 2022 | 0 | — | 0 | 1 |
| 2023 | 1 | — | 0 | 1 |
| 2024 | 1 | — | 0 | 0 |
| 2025 | 1 | — | 0 | 3 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
Iontophoretic drug delivery devices are indicated for the administration of soluble salts or other drugs into the body for medical purposes as an alternative to hypodermic injections. They are also indicated for iontophoretic dermal administration of iONTOCAINE® (Lidocaine HCI 2% and Epinephrine 1:100,000 Topical Solution).
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K063465 · printed Nov 6, 2026
Cite this page
510(k) Report. “K063465: Champion Iontophoretic Drug Delivery Device.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K063465
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026